Cargando…
Quality of life measured by EQ-5D at different treatment time points for coronary artery disease: protocol for a systematic review and meta-analysis
INTRODUCTION: Cardiovascular disease is estimated to affect 423 million people globally. It caused 18 million deaths in 2017 and is projected to cost US$1 trillion by 2030 worldwide. Coronary artery disease (CAD) is the most common type of cardiovascular disease; CAD treatments can affect patients’...
Autores principales: | Lum, Elaine, McCreanor, Victoria, Luo, Nan, Graves, Nicholas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394179/ https://www.ncbi.nlm.nih.gov/pubmed/32727739 http://dx.doi.org/10.1136/bmjopen-2020-039311 |
Ejemplares similares
-
Pharmaceutical use and costs in patients with coronary artery disease, using Australian observational data
por: McCreanor, Victoria, et al.
Publicado: (2019) -
Reducing waste in collection of quality-of-life data through better reporting: a case study
por: McCreanor, Victoria, et al.
Publicado: (2022) -
A systematic review and critical analysis of cost-effectiveness studies for coronary artery disease treatment
por: McCreanor, Victoria, et al.
Publicado: (2018) -
Cost-effectiveness analysis of percutaneous coronary intervention for single-vessel coronary artery disease: an economic evaluation of the ORBITA trial
por: McCreanor, Victoria, et al.
Publicado: (2021) -
Responsiveness and minimal clinically important difference of EQ-5D-5L in patients with coronary heart disease after percutaneous coronary intervention: A longitudinal study
por: Zheng, Yu, et al.
Publicado: (2023)